36
https://pubmed.ncbi.nlm.nih.gov/38116108
The abstract reports a study and systematic review which suggest that intravenous cangrelor may be a safe and effective antiplatelet therapy for neuroendovascular procedures, with low rates of bleeding and ischemic events.
